+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoinjectors - Market Analysis, Trends, and Forecasts

  • ID: 4804455
  • Report
  • 159 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbvie
  • Antares Pharma, Inc.
  • Consort Medical Plc
  • Eli Lilly And Company
  • Haselmeier Gmbh
  • Mylan Nv
  • MORE
Autoinjectors market worldwide is projected to grow by US$89.1 Billion, driven by a compounded growth of 22.7%. Rheumatoid Arthritis, one of the segments analyzed and sized in this study, displays the potential to grow at over 24.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$41.9 Billion by the year 2025, Rheumatoid Arthritis will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 20.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.9 Billion to the region's size and clout in the next 5 to 6 years. Over US$3.2 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Rheumatoid Arthritis will reach a market size of US$1.7 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 27.1% over the next couple of years and add approximately US$20.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AbbVie, Inc.
  • Amgen, Inc.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Company
  • Consort Medical PLC
  • Eli Lilly and Company
  • Haselmeier GmbH
  • Mylan NV
  • Owen Mumford Ltd.
  • SHL Group
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbvie
  • Antares Pharma, Inc.
  • Consort Medical Plc
  • Eli Lilly And Company
  • Haselmeier Gmbh
  • Mylan Nv
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of Drugs Drives Demand

North America: The Largest Market for Autoinjectors

Global Competitor Market Shares

Autoinjectors Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

Global Epinephrine Autoinjector market: Percentage Breakdown of Volume Sales by Leading Players for the Year 2019E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Targeted Therapies such as Cancer, Rheumatoid Arthritis, Multiple Sclerosis and Diabetes: A Strong Growth Driver

Number of New Cases of Cancer Worldwide for the Years 2012, 2015, 2020, 2025 and 2030

Diabetes Prevalence in the Age-Group of 20-79 Years in Millions by Region for the Years 2018, 2021 and 2025

Global Injectable Drug Delivery Market: Revenues in US$ Billion for the Years 2016, 2018, 2020, 2022 and 2024

Rising Incidence of Anaphylaxis and Increased Prescription Rate of Epinephrine Autoinjectors Boosts Market Demand

Increasing Number of Regulatory Approvals for Autoinjectors in Various Diseases

Generic Autoinjectors Take Center Stage

Patent Expiry of Biologics to Drive the Demand for Biosimilars

Strong Government Support and Favorable Reimbursement Policies Propel Market Growth

Challenges

Development of Autoinjectors for Multiple Drug Viscosities: A Major Challenge

Increasing Demand for Alternative Drug Delivery Modes Hampers Market Growth

Emergence of Oral Diabetic Agents, Oral Insulin and Epinephrine Nasal Sprays Poses Huge Challenge for Autoinjectors Market

Product Overview

Autoinjector: Definition

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Autoinjectors Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Autoinjectors Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Autoinjectors Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Rheumatoid Arthritis (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Rheumatoid Arthritis (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Rheumatoid Arthritis (Therapy) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Multiple Sclerosis (Therapy) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Multiple Sclerosis (Therapy) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Multiple Sclerosis (Therapy) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Anaphylaxis (Therapy) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Anaphylaxis (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Anaphylaxis (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Diabetes (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Diabetes (Therapy) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Diabetes (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Therapies (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Therapies (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Therapies (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Autoinjectors Market Share (in %) by Company: 2019 & 2025

TABLE 19: United States Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 20: Autoinjectors Market in the United States by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 21: United States Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

CANADA

TABLE 22: Canadian Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 23: Canadian Autoinjectors Historic Market Review by Therapy in US$ Million: 2009-2017

TABLE 24: Autoinjectors Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

JAPAN

TABLE 25: Japanese Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025

TABLE 26: Autoinjectors Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 27: Japanese Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

CHINA

TABLE 28: Chinese Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 29: Autoinjectors Historic Market Analysis in China in US$ Million by Therapy: 2009-2017

TABLE 30: Chinese Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Autoinjectors Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 31: European Autoinjectors Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 32: Autoinjectors Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 33: European Autoinjectors Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: European Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 35: Autoinjectors Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 36: European Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

FRANCE

TABLE 37: Autoinjectors Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 38: French Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2009-2017

TABLE 39: French Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

GERMANY

TABLE 40: Autoinjectors Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 41: German Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 42: German Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ITALY

TABLE 43: Italian Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 44: Autoinjectors Historic Market Analysis in Italy in US$ Million by Therapy: 2009-2017

TABLE 45: Italian Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 46: United Kingdom Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025

TABLE 47: Autoinjectors Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 48: United Kingdom Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

SPAIN

TABLE 49: Spanish Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 50: Spanish Autoinjectors Historic Market Review by Therapy in US$ Million: 2009-2017

TABLE 51: Autoinjectors Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

RUSSIA

TABLE 52: Russian Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 53: Autoinjectors Market in Russia by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 54: Russian Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 55: Rest of Europe Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 56: Autoinjectors Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 57: Rest of Europe Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 58: Asia-Pacific Autoinjectors Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 59: Autoinjectors Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 60: Asia-Pacific Autoinjectors Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 61: Autoinjectors Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: Asia-Pacific Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2009-2017

TABLE 63: Asia-Pacific Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 64: Autoinjectors Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 65: Australian Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 66: Australian Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

INDIA

TABLE 67: Indian Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 68: Indian Autoinjectors Historic Market Review by Therapy in US$ Million: 2009-2017

TABLE 69: Autoinjectors Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

SOUTH KOREA

TABLE 70: Autoinjectors Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 71: South Korean Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 72: Autoinjectors Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 73: Rest of Asia-Pacific Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025

TABLE 74: Autoinjectors Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 75: Rest of Asia-Pacific Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 76: Latin American Autoinjectors Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 77: Autoinjectors Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 78: Latin American Autoinjectors Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 79: Latin American Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 80: Autoinjectors Historic Market Analysis in Latin America in US$ Million by Therapy: 2009-2017

TABLE 81: Latin American Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 82: Argentinean Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 83: Autoinjectors Market in Argentina in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 84: Argentinean Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

BRAZIL

TABLE 85: Autoinjectors Market in Brazil by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 86: Brazilian Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2009-2017

TABLE 87: Brazilian Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

MEXICO

TABLE 88: Autoinjectors Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 89: Mexican Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 90: Mexican Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 91: Rest of Latin America Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 92: Autoinjectors Market in Rest of Latin America by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 93: Rest of Latin America Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 94: The Middle East Autoinjectors Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 95: Autoinjectors Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 96: The Middle East Autoinjectors Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 97: The Middle East Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 98: The Middle East Autoinjectors Historic Market by Therapy in US$ Million: 2009-2017

TABLE 99: Autoinjectors Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

IRAN

TABLE 100: Iranian Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025

TABLE 101: Autoinjectors Market in Iran: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 102: Iranian Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

ISRAEL

TABLE 103: Israeli Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 104: Autoinjectors Market in Israel in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 105: Israeli Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 106: Saudi Arabian Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 107: Autoinjectors Historic Market Analysis in Saudi Arabia in US$ Million by Therapy: 2009-2017

TABLE 108: Saudi Arabian Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 109: Autoinjectors Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 110: United Arab Emirates Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 111: Autoinjectors Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 112: Autoinjectors Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 113: Rest of Middle East Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 114: Rest of Middle East Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

AFRICA

TABLE 115: African Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 116: Autoinjectors Market in Africa by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 117: African Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE

ANTARES PHARMA, INC.

CONSORT MEDICAL PLC

ELI LILLY AND COMPANY

HASELMEIER GMBH

MYLAN NV

OWEN MUMFORD

SHL GROUP

TEVA PHARMACEUTICAL INDUSTRIES

YPSOMED AG

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbvie
  • Antares Pharma, Inc.
  • Consort Medical Plc
  • Eli Lilly And Company
  • Haselmeier Gmbh
  • Mylan Nv
  • Owen Mumford
  • Shl Group
  • Teva Pharmaceutical Industries
  • Ypsomed Ag
Note: Product cover images may vary from those shown
Adroll
adroll